RecruitingNot ApplicableNCT06319573

The Impact of Personalized Prognostic Counseling on IVF Patient's Experience and Treatment Utilization

Evaluation of in Vitro Fertilisation Patients' Experience With a Personalized Prognostic Counseling Strategy and Its Impact on Treatment Utilization and Discontinuation


Sponsor

Ginefiv

Enrollment

366 participants

Start Date

Mar 19, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study will be conducted in two phases. In the first phase, research subjects will be assigned to receive standard counseling. In the second phase, research subjects will receive Univfy counseling.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 43 Years

Inclusion Criteria1

  • Patients between 18-43 in age and their healthcare providers have determined that IVF treatment using the patients' own eggs is indicated.

Exclusion Criteria9

  • Same sex couples
  • Patients undergoing DuoStim and/or PGT-M/-SR
  • Patients considering egg freezing rather than IVF
  • Patients considering the use of donor eggs or gestational carrier
  • Patients with contraindications to receiving the Univfy® PreIVF Report For Patients Under 40 Using Their Own Eggs. Those contraindications are:
  • Patients who are perimenopausal or menopausal
  • Patients who have very poor IVF results in the past, including:
  • extremely poor oocyte/embryo quality, no embryos to transfer,
  • no euploid embryos on PGT-A, no blastocysts in extended culture

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCounseling Supported by Univfy® Report

The intervention consists of patients being counseled with the Univfy® PreIVF report during their second consultation. They will also be asked to fill in the same anonymous online questionnaire.

OTHERStandard Counseling

Patients in this group will be counseled as per standard care during their second consultation. They will be asked to complete an anonymous online validated questionnaire (see below) to assess their responses to the anonymous online questionnaire after consultation.


Locations(2)

Ginefiv S.L

Barcelona, Spain

Ginefiv S.L

Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06319573


Related Trials